日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Therapeutic progress in leptomeningeal metastasis from EGFR mutant non-small cell lung cancer: a clinical medicine review

EGFR突变型非小细胞肺癌脑膜转移的治疗进展:临床医学综述

Ding, Tianyi; Xie, Yuwen; Ding, Ming

Acetylation-induced degradation of ECHS1 enhances BCAA accumulation and proliferation in KRAS-mutant colorectal cancer.

ECHS1 乙酰化诱导降解可增强 KRAS 突变型结直肠癌中 BCAA 的积累和增殖

Li Zhenkang, Liu Zhengyu, Lin Mingdao, Pan Huayang, Liu Yuechen, Liu Yang, Xie Yuwen, Zhang Jinchao, Guan Shenyuan, Li Yongsheng, Zhu Mulan, Fang Yuan, Shen Zhiyong, Deng Haijun

Furmonertinib in uncommon EGFR-mutated non-small cell lung cancer with central nervous system metastases: A retrospective cohort study

呋莫替尼治疗罕见的EGFR突变型非小细胞肺癌伴中枢神经系统转移:一项回顾性队列研究

Xie, Yuwen; Fang, Hehui; Cheng, Wanwan; Xu, Ting; Xu, Shu; Yu, Chuanyong; Liu, Yong; Fang, Shencun

Correction: Identification of a metabolic-immune signature associated with prognosis in colon cancer and exploration of potential predictive efficacy of immunotherapy response

更正:结肠癌预后相关代谢免疫特征的鉴定及免疫治疗反应潜在预测效能的探索

Xie, Yuwen; Guan, Shenyuan; Li, Zhenkang; Cai, Guohao; Liu, Yuechen; Li, Guoxin; Huang, Ping; Lin, Mingdao

Real-world study of first-line therapy with aumolertinib for elderly patients with non-small cell lung cancer harboring EGFR mutation

一项真实世界研究评估了奥莫替尼一线治疗携带 EGFR 突变的非小细胞肺癌老年患者的疗效。

Liu, Na; Xu, Shu; Xie, Yuwen; Xu, Ting; Fang, Hehui; Wang, Xiaoyue; Yang, Liangfeng; Fang, Shencun